C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/02/2002	EP0861268B1 Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes
10/02/2002	EP0793503B1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
10/02/2002	EP0792281B1 Process for purification of factor viii
10/02/2002	EP0668933B1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
10/02/2002	CN1372595A Method of inhibiting the formation of by-product in the production of genetically modified polypeptide
10/02/2002	CN1372569A Keratinocyte growth factor-2
10/02/2002	CN1372568A Vaccin
10/02/2002	CN1371994A Recombinant hirudin expressed by using yeast secretary
10/02/2002	CN1371917A Liver cance high-expression gene, its coded protein and use
10/02/2002	CN1371916A Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use
10/02/2002	CN1371915A Novel human cell endocytic regulatory protein, its coding sequence and use
10/01/2002	US6458943 hD54 polynucleotides
10/01/2002	US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance
10/01/2002	US6458931 Immunoassay, immunotherapy; cancer; side effect reduction
10/01/2002	US6458928 Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swollenins
10/01/2002	US6458592 Transfecting antibody-producing cell with homology-targeting vector with lox site; genetic engineering and expression
10/01/2002	US6458581 Carrying out in vitro the complete developmental sequence culture of protozoa in an axenic liquid culture, serum-free and buffered; contains a basic medium for insect cells and an inorganic salt, a source of amino acids and a sugar
10/01/2002	US6458571 Excitatory amino acid transporter 3, EAAT3, polypeptides
10/01/2002	US6458565 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers
10/01/2002	US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation
10/01/2002	US6458563 Dna which encodes protein of defined amino acid sequence; stable, less immunogenic treatment of hemophilia
10/01/2002	US6458561 Human NIM1 kinase
10/01/2002	US6458529 Assays for promoter operability in central nervous system cells
10/01/2002	US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus
10/01/2002	US6458367 Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/01/2002	US6458366 Compounds and methods for diagnosis of tuberculosis
10/01/2002	US6458364 Non-splicing variants of gp350/220
10/01/2002	US6458362 Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes
10/01/2002	US6458360 Soluble complement regulatory molecules
10/01/2002	US6458359 Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans
10/01/2002	US6458356 Antibody-induced apoptosis
10/01/2002	US6458353 Anti-CCR2 antibodies and methods of use therefor
10/01/2002	US6458350 ULBP DNA and polypeptides
10/01/2002	US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing
10/01/2002	US6458026 Transfection complex comprising a first component comprising one or more lipids, a second component comprising an oligolysine linked via a peptide bond to an integrin-binding peptide, and a third component comprising a nucleic acid
10/01/2002	CA2224460C Process for producing gm2 specific antibodies
10/01/2002	CA2220461C Therapeutic compounds comprised of anti-fc receptor antibodies
10/01/2002	CA2168459C Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein
10/01/2002	CA2119930C Production of chimeric antibodies - a combinatorial approach
10/01/2002	CA2109602C Methods for producing members of specific binding pairs
10/01/2002	CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
10/01/2002	CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
10/01/2002	CA2011304C Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe
10/01/2002	CA1341389C Human granulocyte colony stimulating factor
09/2002
09/28/2002	CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
09/26/2002	WO2002075507A2 Anti-bacterial vaccine compositions
09/26/2002	WO2002075275A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof
09/26/2002	WO2002074979A2 Expression profiles and methods of use
09/26/2002	WO2002074972A1 Method of assaying lupus anticoagulant and assay reagent
09/26/2002	WO2002074969A2 Matrix attachment regions and methods for use thereof
09/26/2002	WO2002074968A1 Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof
09/26/2002	WO2002074964A2 Polypeptides derived from rna polymerases and use thereof
09/26/2002	WO2002074962A1 Acetyllysine-recognizing monoclonal antibody and process for producing the same
09/26/2002	WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1
09/26/2002	WO2002074952A2 Nucleic acid which is stabilised against decomposition
09/26/2002	WO2002074929A2 Evolving new molecular function
09/26/2002	WO2002074928A2 Fusion peptides isolatable by phase transition
09/26/2002	WO2002074926A2 Myo-inositol oxygenases
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074911A2 Identification of gene expression alterations underlying the aging process in mammals
09/26/2002	WO2002074904A2 Rearranged squamous cell carcinoma antigen genes ii
09/26/2002	WO2002074808A2 Modified insulin with reduced immunogenicity
09/26/2002	WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins
09/26/2002	WO2002074806A2 New interferon beta-like molecules
09/26/2002	WO2002074805A1 Soluble rage protein
09/26/2002	WO2002074798A2 The genome of a bifidobacterium
09/26/2002	WO2002074796A2 Histidine phosphatase interacting protein with 240kd
09/26/2002	WO2002074792A1 Fo-6979 substances and process for producing the same
09/26/2002	WO2002074783A2 Modified interferon beta with reduced immunogenicity
09/26/2002	WO2002074326A2 Urocortin-iii and uses thereof
09/26/2002	WO2002074251A2 Monoclonal antibody therapy for pancreas cancer
09/26/2002	WO2002074250A2 Methods and reagents for decreasing clinical reaction to allergy
09/26/2002	WO2002074239A2 Compositions and methods for the treatment and clinical remission of psoriasis
09/26/2002	WO2002062999A8 Proteins and nucleic acids encoding same
09/26/2002	WO2002062957A3 Ter sites and ter binding proteins
09/26/2002	WO2002038609A3 Apolipoprotein conjugates
09/26/2002	WO2002031155A3 Gene cluster for ramoplanin biosynthesis
09/26/2002	WO2002029084A3 Industrial-scale serum-free production of recombinant factor vii in mammalian cells
09/26/2002	WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
09/26/2002	WO2002000710A3 B7-like molecules and uses thereof
09/26/2002	WO2001098332A3 Secreted redox proteins
09/26/2002	WO2001094418A3 Leader peptides for enhancing secretion of recombinant protein from a host cell
09/26/2002	WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
09/26/2002	WO2001083775A3 Proteases
09/26/2002	WO2001047953A3 Antibodies against plasma cells
09/26/2002	WO2001037628A3 Method for obtaining biotechnological valuable substances
09/26/2002	WO2001025401A9 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins
09/26/2002	WO2001019861A9 Apo-2 receptor antibodies
09/26/2002	WO2001019393A9 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems
09/26/2002	WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use
09/26/2002	US20020138872 Transgenic plants; enhanced defense mechanisms to combat plant diseases; disease resistant plants
09/26/2002	US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
09/26/2002	US20020137921 Oligonucleotides having chiral phosphorus linkages
09/26/2002	US20020137909 Designated as "PRO19598" polypeptides; diagnosis and treatment of tumors
09/26/2002	US20020137894 Megakaryocyte stimulating factors
09/26/2002	US20020137891 Inserting a nucleic acid sequence encoding a heterologous polypeptide into a nucleic acid sequence encoding subunit of an oligomerisable protein scaffold, incorporating it into expression vector to express nucleic acid to produce monomer
09/26/2002	US20020137886 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction
09/26/2002	US20020137679 Thrombospondins-1 and -2 are adhesive glycoproteins proteins that are angiogenesis inhibitors; portions of TSP- 1, TSP-2, endostatin, angiostatin, platelet factor 4, or prolactin linked to a portion of cartilage oligoeric matrix protein
09/26/2002	US20020137673 Factor VII glycoforms
09/26/2002	US20020137204 Conditioned medium collected from a culture of feeder cells with laminin or collagen

1 ... 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 ... 1125